Jiangxi Sanyuan Pharmaceutical Co., Ltd. – FDA Inspection, Nov 10, 2017

Record Details

This FDA Inspection record concerns Jiangxi Sanyuan Pharmaceutical Co., Ltd., with an inspection on November 10, 2017, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Jiangxi Sanyuan Pharmaceutical Co., Ltd.
Inspection Date: November 10, 2017
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Marijo B. Kambere

View Company Profile

ID · b08466b2-8e9f-4941-a8ac-9d442b478cdc

Inspection Facts

Inspection number: 1035044
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Jiangxi Sanyuan Pharmaceutical Co., Ltd.

FDA Inspection

Jiangxi Sanyuan Pharmaceutical Co., Ltd.November 10, 2017

Jiangxi Sanyuan Pharmaceutical Co., Ltd. – FDA Inspection, Nov 10, 2017

Record Details

This FDA Inspection record concerns Jiangxi Sanyuan Pharmaceutical Co., Ltd., with an inspection on November 10, 2017, issued by the Office of Inspections and Investigations, covering human drugs.